Next Article in Journal
Formulation of Multicomponent Chrysin-Hydroxy Propyl β Cyclodextrin-Poloxamer Inclusion Complex Using Spray Dry Method: Physicochemical Characterization to Cell Viability Assessment
Next Article in Special Issue
Smart Biomimetic Nanozymes for Precise Molecular Imaging: Application and Challenges
Previous Article in Journal
Aspirin Inhibits Fibronectin Expression and Reverses Fibronectin-Mediated Cell Invasiveness by Activating Akt Signaling in Preeclampsia
Previous Article in Special Issue
Enzyme-Enhanced Codelivery of Doxorubicin and Bcl-2 Inhibitor by Electrospun Nanofibers for Synergistic Inhibition of Prostate Cancer Recurrence
 
 
Article
Peer-Review Record

Albumin-Based Zn (II)-Quercetin Enzyme Mimic Scavenging ROS for Protection against Cardiotoxicity Induced by Doxorubicin

Pharmaceuticals 2022, 15(12), 1524; https://doi.org/10.3390/ph15121524
by Zehua Shao 1,†, Ran Li 1,2,†, Dongxing Shao 2,3, Hao Tang 1,2,* and Yu Han 1,*
Reviewer 1:
Reviewer 2:
Pharmaceuticals 2022, 15(12), 1524; https://doi.org/10.3390/ph15121524
Submission received: 7 November 2022 / Revised: 3 December 2022 / Accepted: 6 December 2022 / Published: 8 December 2022
(This article belongs to the Special Issue Enzyme-Based Drug Delivery Systems)

Round 1

Reviewer 1 Report

Comments are indicated in the attached file.

Comments for author File: Comments.pdf

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Reviewer 2 Report

I've done my review of the manuscript entitled " Albumin-based Zn (II)-Quercetin Enzyme Mimic Scavenging ROS for Protection against Cardiotoxicity Induced by Doxorubicin by Zehua Shao and colleagues. 

In this manuscript, the authors reported the preparation of novel enzyme mimic via coordinated albumin, Zinc Ion (Zn2+), and quercetin, the enzyme mimics capable of simultaneously increasing the biocompatibility and it efficiently overcome the drawbacks of free quercetin achieved long circulation in vivo. They evaluated the efficacy of Que NPs scavenging free radicals for against cardiotoxicity induced by doxorubicin through cellular and animal models.

I find the topic very interesting however it needs minor revision. I would like to point out some issues with suggestions before publication.

Title: It’s fine

 

Abstract: The concern is that the authors failed to show a serious attitude toward the abstract format. The abstract must be more precise and must refer to the real results.

Introduction:  1. The introduction doesn't provide a good, generalized background of the topic that quickly gives the reader an appreciation.

2. To make the introduction more substantial, the author should provide several updated references to substantiate the claim made. 

 

Results and Discussion: Results are not clearly presented and is flawed and frustrating seriously. I dint notices characterization data

 

 

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Back to TopTop